Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

Diagnostic testing for Legionnaires' disease.

Pierre DM, Baron J, Yu VL, Stout JE.

Ann Clin Microbiol Antimicrob. 2017 Aug 29;16(1):59. doi: 10.1186/s12941-017-0229-6. Review.

2.

Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors.

Schenkel LB, DiMauro EF, Nguyen HN, Chakka N, Du B, Foti RS, Guzman-Perez A, Jarosh M, La DS, Ligutti J, Milgram BC, Moyer BD, Peterson EA, Roberts J, Yu VL, Weiss MM.

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3817-3824. doi: 10.1016/j.bmcl.2017.06.054. Epub 2017 Jun 26.

PMID:
28684121
3.

Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors.

Sparling BA, Yi S, Able J, Bregman H, DiMauro EF, Foti RS, Gao H, Guzman-Perez A, Huang H, Jarosh M, Kornecook T, Ligutti J, Milgram BC, Moyer BD, Youngblood B, Yu VL, Weiss MM.

Medchemcomm. 2016 Dec 2;8(4):744-754. doi: 10.1039/c6md00578k. eCollection 2017 Apr 1.

4.

Editorial Commentary: Control of HIV for Men Who Have Sex With Men in China: A Role for the Internet?

Shen Y, Yu VL, Lu H.

Clin Infect Dis. 2016 Jun 1;62(11):1448-9. doi: 10.1093/cid/ciw172. Epub 2016 Apr 29. No abstract available.

PMID:
27129467
5.

Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.

Schenkel LB, Olivieri PR, Boezio AA, Deak HL, Emkey R, Graceffa RF, Gunaydin H, Guzman-Perez A, Lee JH, Teffera Y, Wang W, Youngblood BD, Yu VL, Zhang M, Gavva NR, Lehto SG, Geuns-Meyer S.

J Med Chem. 2016 Mar 24;59(6):2794-809. doi: 10.1021/acs.jmedchem.6b00039. Epub 2016 Mar 4.

PMID:
26942860
6.

Postobstructive Pneumonia: An Underdescribed Syndrome.

Abers MS, Sandvall BP, Sampath R, Zuno C, Uy N, Yu VL, Stager CE, Musher DM.

Clin Infect Dis. 2016 Apr 15;62(8):957-61. doi: 10.1093/cid/civ1212. Epub 2016 Feb 21.

7.

Editorial commentary: risk assessment and prediction for health care-associated Legionnaires' disease: percent distal site positivity as a cut-point.

Pierre D, Stout JE, Yu VL.

Am J Infect Control. 2014 Nov;42(11):1248-50. doi: 10.1016/j.ajic.2014.06.032. Epub 2014 Oct 30. No abstract available.

PMID:
25444274
8.

Legionnaires' disease: importance of high index of suspicion in patients in the ICU with community-acquired pneumonia.

Yu VL.

Chest. 2014 Feb;145(2):202-205. doi: 10.1378/chest.13-2170. No abstract available.

PMID:
24493498
9.

Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia.

Afzal Z, Minard CG, Stager CE, Yu VL, Musher DM.

Am J Ther. 2016 May-Jun;23(3):e766-72. doi: 10.1097/MJT.0000000000000018.

PMID:
24351801
10.

Computer keyboard covers impregnated with a novel antimicrobial polymer significantly reduce microbial contamination.

D'Antonio NN, Rihs JD, Stout JE, Yu VL.

Am J Infect Control. 2013 Apr;41(4):337-9. doi: 10.1016/j.ajic.2012.03.030. Epub 2012 Oct 2.

PMID:
23036480
11.

Legionellosis in nursing homes and long-term care facilities: what the Slovenian experience can teach us.

Yu VL, Stout JE.

Scand J Infect Dis. 2012 Sep;44(9):716-9. doi: 10.3109/00365548.2012.713118. No abstract available.

PMID:
22897243
12.

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer.

Lewis RT, Bode CM, Choquette DM, Potashman M, Romero K, Stellwagen JC, Teffera Y, Moore E, Whittington DA, Chen H, Epstein LF, Emkey R, Andrews PS, Yu VL, Saffran DC, Xu M, Drew A, Merkel P, Szilvassy S, Brake RL.

J Med Chem. 2012 Jul 26;55(14):6523-40. doi: 10.1021/jm3005866. Epub 2012 Jul 10.

PMID:
22734674
13.

Prospective observational study of chronic rhinosinusitis: environmental triggers and antibiotic implications.

Ferguson BJ, Narita M, Yu VL, Wagener MM, Gwaltney JM Jr.

Clin Infect Dis. 2012 Jan 1;54(1):62-8. doi: 10.1093/cid/cir747. Epub 2011 Nov 22.

PMID:
22114094
14.

Prevention of hospital-acquired legionellosis.

Lin YE, Stout JE, Yu VL.

Curr Opin Infect Dis. 2011 Aug;24(4):350-6. doi: 10.1097/QCO.0b013e3283486c6e. Review.

PMID:
21666459
15.

Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy.

Sun HY, Fujitani S, Quintiliani R, Yu VL.

Chest. 2011 May;139(5):1172-1185. doi: 10.1378/chest.10-0167. Review.

PMID:
21540216
16.

Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source.

Fujitani S, Sun HY, Yu VL, Weingarten JA.

Chest. 2011 Apr;139(4):909-919. doi: 10.1378/chest.10-0166. Review.

PMID:
21467058
17.

Controlling Legionella in hospital drinking water: an evidence-based review of disinfection methods.

Lin YE, Stout JE, Yu VL.

Infect Control Hosp Epidemiol. 2011 Feb;32(2):166-73. doi: 10.1086/657934. Review.

PMID:
21460472
18.

Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw.

Yu VL.

Lancet Infect Dis. 2011 Mar;11(3):248-52. doi: 10.1016/S1473-3099(11)70005-6.

PMID:
21371658
20.

Revisiting the hand wipe versus gel rub debate: is a higher-ethanol content hand wipe more effective than an ethanol gel rub?

D'Antonio NN, Rihs JD, Stout JE, Yu VL.

Am J Infect Control. 2010 Nov;38(9):678-82. doi: 10.1016/j.ajic.2010.07.002.

PMID:
21034977
21.

Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study.

Nguyen MH, Husain S, Clancy CJ, Peacock JE, Hung CC, Kontoyiannis DP, Morris AJ, Heath CH, Wagener M, Yu VL.

J Infect. 2010 Nov;61(5):419-26. doi: 10.1016/j.jinf.2010.08.004. Epub 2010 Aug 21.

PMID:
20732350
22.

Environmental culturing for Legionella: can we build a better mouse trap?

Stout JE, Yu VL.

Am J Infect Control. 2010 Jun;38(5):341-3. doi: 10.1016/j.ajic.2010.02.002. No abstract available.

PMID:
20569848
23.

Neonatal legionellosis: the tip of the iceberg for pediatric hospital-acquired pneumonia?

Yu VL, Lee TC.

Pediatr Infect Dis J. 2010 Mar;29(3):282-4. doi: 10.1097/INF.0b013e3181d1dfda. Review. No abstract available.

PMID:
20190615
24.

Legionella in an ice machine may be a sentinel for drinking water contamination.

Yu VL, Stout JE.

Infect Control Hosp Epidemiol. 2010 Mar;31(3):317; author reply 318. doi: 10.1086/651067. No abstract available.

PMID:
20109077
25.

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL.

Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S26-33. doi: 10.1086/647940.

PMID:
20067390
26.
27.

Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care.

Feldman C, Alanee S, Yu VL, Richards GA, Ortqvist A, Rello J, Chiou CC, Chedid MB, Wagener MM, Klugman KP; International Pneumococcal Study Group.

Clin Microbiol Infect. 2009 Sep;15(9):850-7. doi: 10.1111/j.1469-0691.2009.02901.x.

28.

Treatment strategies for Legionella infection.

Pedro-Botet ML, Yu VL.

Expert Opin Pharmacother. 2009 May;10(7):1109-21. doi: 10.1517/14656560902900820 . Review.

PMID:
19405787
29.

A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.

File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, Yu VL, Singer ME, Adelman MH.

Int J Antimicrob Agents. 2009 Jan;33(1):58-64. doi: 10.1016/j.ijantimicag.2008.07.019. Epub 2008 Oct 1.

PMID:
18835762
30.

Community-acquired legionnaires disease: implications for underdiagnosis and laboratory testing.

Yu VL, Stout JE.

Clin Infect Dis. 2008 May 1;46(9):1365-7. doi: 10.1086/586742. No abstract available.

PMID:
18419437
31.

Cooling towers and legionellosis: a conundrum with proposed solutions.

Yu VL.

Int J Hyg Environ Health. 2008 Jul;211(3-4):229-34. doi: 10.1016/j.ijheh.2008.02.003. Epub 2008 Apr 11. No abstract available.

PMID:
18406666
32.

Mycobacterium monacense: a mycobacterial pathogen that causes infection of the hand.

Taieb A, Ikeguchi R, Yu VL, Rihs JD, Sharma M, Wolfe J, Wollstein R.

J Hand Surg Am. 2008 Jan;33(1):94-6. doi: 10.1016/j.jhsa.2007.10.016.

PMID:
18261672
33.

Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, von Gottberg A, Goossens H, Wagener MM, Benedi VJ; International Klebseilla Study Group.

Emerg Infect Dis. 2007 Jul;13(7):986-93. doi: 10.3201/eid1307.070187.

34.

Legionnaires' disease - Results of a multicentre Canadian study.

Marrie TJ, De Carolis E, Yu VL, Stout J; Canadian Community-Acquired Pneumonia Investigators.

Can J Infect Dis. 2003 May;14(3):154-8.

35.

New antimicrobial agents as therapy for resistant gram-positive cocci.

Lentino JR, Narita M, Yu VL.

Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):3-15. Review.

PMID:
17899228
36.

Effect of pipe corrosion scales on chlorine dioxide consumption in drinking water distribution systems.

Zhang Z, Stout JE, Yu VL, Vidic R.

Water Res. 2008 Jan;42(1-2):129-36. Epub 2007 Aug 28.

PMID:
17884130
37.

Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.

Narita M, Tsuji BT, Yu VL.

Pharmacotherapy. 2007 Aug;27(8):1189-97. Review.

PMID:
17655517
38.

Safety and efficacy of chlorine dioxide for Legionella control in a hospital water system.

Zhang Z, McCann C, Stout JE, Piesczynski S, Hawks R, Vidic R, Yu VL.

Infect Control Hosp Epidemiol. 2007 Aug;28(8):1009-12. Epub 2007 Jun 29.

PMID:
17620253
39.

Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.

Schentag JJ, Klugman KP, Yu VL, Adelman MH, Wilton GJ, Chiou CC, Patel M, Lavin B, Paladino JA.

Int J Antimicrob Agents. 2007 Sep;30(3):264-9. Epub 2007 Jun 22.

PMID:
17587549
40.

Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations.

Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL; Legionella Study Group.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):818-24. Epub 2007 Jun 5.

PMID:
17564984
41.

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study.

Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Ortqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP; International Pneumococcal Study Group.

Clin Infect Dis. 2007 Jul 1;45(1):46-51. Epub 2007 May 31.

PMID:
17554699
42.

Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome.

Feldman C, Klugman KP, Yu VL, Ortqvist A, Choiu CC, Chedid MB, Rello J, Wagener M; International Pneumococcal Study Group.

J Infect. 2007 Aug;55(2):125-35. Epub 2007 May 24.

PMID:
17524486
43.

A new category--healthcare-associated pneumonia: a good idea, but problems with its execution.

Fujitani S, Yu VL.

Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):627-31. No abstract available.

PMID:
17024504
44.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
45.

Severe pneumococcal pneumonia: new strategies for management.

Chiou CC, Yu VL.

Curr Opin Crit Care. 2006 Oct;12(5):470-6. Review.

PMID:
16943728
46.

Quantitative cultures for diagnosing ventilator-associated pneumonia: a critique.

Fujitani S, Yu VL.

Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S106-13. Review.

PMID:
16894512
47.

Effect of flow regimes on the presence of Legionella within the biofilm of a model plumbing system.

Liu Z, Lin YE, Stout JE, Hwang CC, Vidic RD, Yu VL.

J Appl Microbiol. 2006 Aug;101(2):437-42.

48.

Problem pathogens: paediatric legionellosis--implications for improved diagnosis.

Greenberg D, Chiou CC, Famigilleti R, Lee TC, Yu VL.

Lancet Infect Dis. 2006 Aug;6(8):529-35. Review.

PMID:
16870531
49.

No impact of penicillin resistance on mortality.

Klugman KP, Yu VL.

Clin Infect Dis. 2006 Jul 15;43(2):261; author reply 261-2. No abstract available.

PMID:
16779757

Supplemental Content

Support Center